Chembio is a leading point of care diagnostics company focused on detecting and diagnosing infectious diseases. Chembio Labs has evolved out of research at the Baylor College of Medicine, one of the world's top medical schools, and through collaborations with academia and industry leaders in developing innovative new diagnostic tests that can be used by physicians to make informed decisions about treatment options for patients.

Latest articles

Cristiano Amon: Qualcomm's 5G Specialist CEO

Cristiano Amon, Qualcomm CEO, has spent two decades at the company while taking on several roles, developing both technical and business expertise.

16 Sep 2024

Qualcomm: Quality Communication and Semiconductor Innovation

Founded in 1985, Qualcomm has transformed the digital communication industry with CDMA technology and its advanced semiconductor business.

13 Sep 2024

Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology

After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.

4 Sep 2024

Ticker symbol

CEMI

Country

🇺🇸 United States